Dierucoyl phosphatidylcholine cas 4235-95-4

Dierucoyl Phosphatidylcholine (CAS 4235-95-4) Product Guide

Table of Contents

• Product Overview & Specifications
• Detailed Applications
• Industry Usage Cases
• Client Success Stories
• Contact for Quotation

Product Overview & Specifications

Detailed Applications

Pharmaceutical Delivery Systems

Enables long-circulating liposomes due to high phase transition temperature (45-50°C), ideal for:

• Cancer drug encapsulation
• RNA vaccine stabilization
• Topical antifungal formulations

Cosmetic Formulations

Superior skin penetration enhancer compared to standard phosphatidylcholines:

• Increases active ingredient absorption by 30-40%
• Reduces transepidermal water loss (TEWL) by 25%
• pH-stable between 4.0-8.5

Industry Usage Cases

Case 1: mRNA Vaccine Adjuvant Development

Challenge: Maintain lipid nanoparticle integrity at 37°C for 72hrs
Solution: 60% Dierucoyl PC in lipid matrix
Result: 92% payload retention vs. 78% with standard DLin-MC3-DMA

Case 2: Anti-Aging Cream Formulation

Challenge: Deliver retinol without irritation
Solution: 5% Dierucoyl PC encapsulation
Result: 3x higher dermal retention vs. traditional liposomes

Client Success Stories

PharmaTech Inc. (USA)

Application: Ocular drug delivery system
Outcome: Achieved 8-hour sustained release in rabbit models
Testimonial: “Reduced dosing frequency by 50% in Phase II trials”

BioCosme Co., Ltd. (South Korea)

Application: Vitamin C serum stabilization
Outcome: Extended shelf life from 6 to 18 months
Testimonial: “Oxidation reduction confirmed via HPLC-UV analysis”

Contact for Technical Consultation

Request batch-specific COA or formulation support:
Email: info@vivalr.com
Tel: (86) 15866781826

Next Steps:
1. Specify required quantity (grams to kilograms)
2. Provide application details for purity optimization
3. Request GMP certification if needed